Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells. - Clement MS; Gammelgaard KR; Nielsen AL; Sorensen BS (Translational lung cancer research, 2020)